Isoflavones: Source and metabolism

Handbook of Nutraceuticals and Functional Foods, Second Edition

Volumn , Issue , 2016, Pages 23-54

  Hendrich, Suzanne ^a   Murphy, Patricia A ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051962087     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (196)

1. Murphy, P.A. Isoflavones in soybean processing, in Nutritionally Enhanced Edible Oil and Oilseed Processing, Eds., N.T. Dunford and H.B. Dunford, AOCS Press, Champaign, IL, 2004, pp. 38-70, chap. 3.
2. Hendrich, S. and Murphy, P.A. Soybean isoflavones: source and metabolism. Ed., R. Wildman, Handbook of Nutraceuticals and Functional Foods, CRC Press, Boca Raton, FL, 2000, pp. 55-75.
3. Murphy, P.A. and Hendrich, S. Phytoestrogens in foods. Adv. Food Nutr. Res., 44: 195-246, 2002.
4. USDA-Iowa State University Database on Isoflavone Content of Food, Release 1.3, 2002. http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html.
5. Bennetau-Pelissero, C., Arnal-Schnebelen, B., Lamothe, V., Sauvant, P., Sagne, J.L., Verbruggen, M.A., Mathey, J., and Lavialle, O. ELISA as a new method to measure genistein and daidzein in food and human fluids. Food Chem. 82: 645-658, 2003.
6. Antonelli, M.L., Faberi, A., Pastorini, E., Samperi, R., and Lagan, A. Simultaneous quantitation of free and conjugated phytoestrogens in Leguminosae by liquid chromatography-tandem mass spectrometry. Talanta 66: 1025-1033, 2005.
7. Peng, Y., Chu, Q., Liu, F., and Ye, J. Determination of isoflavones in soy products by capillary electrophoresis with electrochemical detection. Food Chem. 87: 135-139, 2004.
8. Apers, S., Naessens, T., Van Den Steen, K., Cuyckens, F., Claeys, M., Pieters, L., and Vlietinck, A. Fast high-performance liquid chromatography method for quality control of soy extracts. J. Chromatogr. A, 1038: 107-112, 2004.
9. Klejdus, B., Mikelová, R., Petrlova, J., Potesil, D., Adam, V., Stiborov', M., Hodekc, P., Vacek, J., Kizek, R., and Kuban, V. Determination of isoflavones in soy bits by fast column high-performance liquid chromatography coupled with UV-visible diode-array detection. J. Chromatogr. A, 1084: 71-79, 2005.
10. Klejdus, B., Mikelova, R., Petrlova, J., Potesil, D., Adam, V., Stiborova, M., Hodek, P., Vacek, J., Kizek, R., and Kuban, V. Evaluation of isoflavone aglycon and glycoside distribution in soy plants and soybeans by fast column high-performance liquid chromatography coupled with a diode-array detector. J. Agric. Food Chem. 53: 5848-5852, 2005.
11. Klejdus, B., Mikelová, R., Adam, V., Zehnálek, J., Vacek, J., Kizek, R., and Kubán, V. Liquid chromatographic-mass spectrometric determination of genistin and daidzin in soybean food samples after accelerated solvent extraction with modified content of extraction cell. Anal. Chim. Acta 517:1-11, 2004.
12. Rostango M.A., Palma, M., and Barr, C.G. Short-term stability of soy isoflavones extracts: sample conservation aspects. Food Chem. 93: 557-564, 2005.
13. Lin, F. and Giusti, M.M. Effects of solvent polarity and acidity on the extraction efficiency of isoflavones from soybeans (Glycine max). J. Agric. Food Chem. 53: 3795-3800, 2005.
14. Kawanishi, M., Takamura, E.T., Ermawati, R., Shimohara, C., Sakamoto, M., Matsukawa, K., Matsuda, T., Murahashi, T., Matsui, S., Wakabayashi, K., Watanabe, T., Tashiro, H.Y., and Yagi, T. Detection of genistein as an estrogenic contaminant of river water in Osaka. Environ. Sci. Technol. 38:6424-6429, 2004.
15. Achouri, A., Boye, J.I., and Belanger, D., Soybean isoflavones: efficacy of extraction conditions and effect of food type on extractability. Food Res. Int. 38: 1199-1204, 2005.
16. Park J., Park, H., Jeong, H.J., and De Lumen, B.O. Contents and bioactivities of lunasin, Bowman-Birk inhibitor, and isoflavones in soybean seed. J. Agric. Food Chem. 53: 7686-7690, 2005.
17. Wu, Q., Wang, M., Sciarappa, W.J., and Simon, J.E. LC/UV/ESI-MS analysis of isoflavones in edamame and tofu soybeans. J. Agric. Food Chem. 52: 2763-2769, 2004.
18. Hubert, J., Berger, M. and Dayde, J. Use of simplified HPLC-UV analysis for soyasaponin B determination:study of saponin and isoflavone variability in soybean cultivars and soy-based health food products. J. Agric. Food Chem. 53: 3923-3930, 2005.
19. Lee, J.H., Renita, M., Fioritto, R.J., St. Martin, S.K., Schwartz, S.J., and Vodovotz, Y. Isoflavone characterization and antioxidant activity of Ohio soybeans. J. Agric. Food Chem. 52: 2647-2651, 2004.
20. Yu, O., Shi, J., Hession, A.O., Maxwell, C.A., McGonigle, B., and Odell, J.T. Metabolic engineering to increase isoflavone biosynthesis in soybean seed. Phytochemistry 63: 753-763, 2003.
21. Klump, M.C., Allured, J.L., MacDonald, J., and Balaam, M.M. Determination of isoflavones in soy and selected foods containing soy by extraction, specification, and liquid chromatography: collaborative study. J. Assoc. Off. Anal. Chem. Int. 84: 1865-1883, 2001.
22. Murphy, P.A., Barua, K., and Hauck, C.C. Solvent extraction selection in analysis of isoflavones in soy foods. J. Chromatogr. B, 777: 129-138, 2002.
23. Duke, S.O., Rimando, A.M., Pace, P.F., Reddy, K.N., and Smeda, R.J. Isoflavone, glyphosate, and aminomethylphosphonic acid levels in seeds of glyphosate-treated, glyphosate-resistant soybean. J. Agric. Food Chem. 51: 340-344, 2003.
24. Li, D., Park, J., Park, J.T., Park, C.S., and Park, K.H. Biotechnological Production of Highly soluble daidzein glycosides using thermotoga maritima maltosyltransferase. J. Agric. Food Chem. 52:2561-2567, 2004.
25. Variyov, P.S., Limaye, A. and Sharma, A. Radiation-induced enhancement of antioxidant contents of soybean (Glycine max Merrill). J. Agric. Food Chem. 52: 3385-3388, 2004.
26. Barbosa, A.C.L., Lajolo, F.M., and Genovese, M.I. Influence of temperature, pH and ionic strength on the production of isoflavone-rich soy protein isolates. Food Chem. doi:10.1016/j.foodchem.2005.07.014, 2006.
27. Fukui, K., Tachibana, N., Wanezaki, S., Tsuzaki, S., Takamatsu, K., Yamamoto, T., Hashimoto, Y., and Shimoda, T. Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. J. Agric. Food Chem. 50: 5717-5721, 2002.
28. Rickert, D.A., Johnson, L.A., and Murphy, P.A. Improved fractionation of glycinin and β-conglycinin and partitioning of phytochemicals. J. Agric. Food Chem. 52: 1726-1734, 2004.
29. Rickert, D.A., Meyer, M.A., Hu, J., and Murphy, P.A. Effect of extraction pH and temperature on isoflavone and saponin partitioning and profile during soy protein isolate production. J. Food Sci. 69:C623-C631, 2004.
30. Xu, L., Lamb, K., Layton, L., and Kumar, A. A membrane-based process for recovering isoflavones from a waste stream of soy processing. Food Res. Int. 37: 867-874, 2004.
31. Penalvo, J.L., Nurmi, T., and Adlercreutz, H. A simplified HPLC method for total isoflavones in soy products. Food Chem. 87: 297-305, 2004.
32. Penalvo, J.L., Heinonen, S.M., Nurmi, T., Deyama, T., Nishibe, S., and Adlercreutz, H. Plant lignans in soy-based health supplements. J. Agric. Food Chem. 52: 4133-4138, 2004.
33. Chua, R., Anderson, K., Chen, J., and Hu, M. Quality, labeling accuracy, and cost comparison of purified soy isoflavonoid products. J. Altern. Complement. Med. 10: 1053-1060, 2004.
34. Pinto, M.S., Lajolo, F.M., and Genovese, M.I. Effect of storage temperature and water activity on the content and profile of isoflavones, antioxidant activity and in vitro protein digestibility of soy protein isolates and defatted soy flours. J. Agric. Food Chem. 53: 6340-6346, 2005.
35. Kim, J.J., Kim, S.H., Hahn, S.J., and Chung, I.M., Changing soybean isoflavone composition and concentrations under two different storage conditions over three years. Food Res. Int. 38: 435-444, 2005.
36. Ismail, B. and Hayes, K., Beta-glycosidase activity toward different glycosidic forms of isoflavones. J. Agric. Food. Chem. 53: 4918-4924, 2005.
37. Choi, Y.B., Kim, K.S., and Rhee, J.S. Hydrolysis of soybean isoflavone glucosides by lactic acid bacteria. Biotechnol. Lett. 24; 2113-2116, 2002.
38. Chien, J.T., Hsieh, H.C., Kao, T.H., and Chen, B.H. Kinetic model for studying the conversion and degradation of isoflavones during heating. Food Chem. 91: 425-434, 2005.
39. Setchell, K.D.R. and Cole, S.J. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J. Agric. Food Chem. 51: 4146-4155, 2003.
40. Zhang, Y.C., Albrecht, D., Bomser, J., Schwartz, S.J., and Vodovotz, Y. Isoflavone profile and biological activity of soy bread. J. Agric. Food Chem. 51: 7611-7616, 2003.
41. Hu, J., Lee, S.O., Hendrich, S., and Murphy, P.A. Quantification of the group B soyasaponins by high-performance liquid chromatography. J. Agric Food Chem. 50: 2587-2594, 2002.
42. Kao, T.H., Lu, Y.F., Hsieh, H.C., and Chen, B.H. Stability of isoflavone glucosides during processing of soymilk and tofu. Food Res. Int. 37: 891-900, 2004.
43. Tsangalis, D., Ashton, J.F., McGill, A.E.J., and Shah, N.P. Enzymic transformation of isoflavone phytoestrogens in soymilk by β-glucosidase-producing Bifidobacteria. J. Food Sci. 67: 3104-3113, 2002.
44. Tsangalis, D., Wilcox, G., Shah, N.P., and Stojanovska, L. Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Brit. J. Nutr. 93: 867-877, 2005.
45. Kao F.-J., Su, N.W., and Lee, M.H. Effect of water-to-bean ratio on the contents and compositions of isoflavones in tofu. J. Agric. Food Chem. 52: 2277-2281, 2004.
46. Antignac, J.P., Cariou, R., Le Bizec, B., and Andr, F. New data regarding phytoestrogens content in bovine milk. Food Chem. 87: 275-281, 2004.
47. Wu, M.L., Chang, J.C., Lai, Y.H., Cheng, S.L., and Chiou, R.Y.Y. Enhancement of tofu isoflavone recovery by pretreatment of soy milk and koji enzyme extract. J. Agric. Food Chem. 52: 4785-4790, 2004.
48. Wiseman, H., Casey, K., Clarke, D.B., Barnes, K.A., and Bowey, E. Isoflavone aglycon and glucoconjugate content of high- and low-soy U.K. foods used in nutritional studies. J. Agric. Food Chem. 50: 1404-1410, 2002.
49. Banz, W.J., Peluso, M.R., Winters, T.A., and Shanahan, M.F. Methods of Treating Clinical Diseases with Isoflavones. U.S. Patent 6,592,910, 2003.
50. Bates, G.A. and Bryan, B.A. Process for Separating and Recovering Protein and Isoflavones from a Plant Material. U.S. Patent 6,703,051, 2004.
51. Blatt, Y., Arad, O., Kimelman, E., Cohen, D., Pinto, R., and Rotman, A. Microencapsulated and Controlled-Release Formulations of Isoflavone from Enriched Fractions of Soy and Other Plants. U.S. Patent 6,890,561, 2005.
52. Bombardelli, E. and Gabetta, B. Soya Extract, Process for its Preparation and Pharmaceutical Composition. U.S. Patent 6,607,757, 2003.
53. Bringe, N.A. High Beta-Conglycinin Products and Their Use. U.S. Patent 6,566,134, 2003.
54. Bryan, B.A. and Allred, M.C. Aglucone Isoflavone Enriched Vegetable Flour and Vegetable Grit and Process for Making the Same from a Vegetable Material Containing Isoflavone. U.S. Patent 6,579,561, 2003.
55. Daicho, T. Health Food Products. U.S. Patent 6,793,943, 2004.
56. Empie, M. and Gugger, E. Method of Preparing and using Compositions Extracted from Vegetable Matter for the Treatment of Cancer. U.S. Patent 6,900,240, 2005.
57. Forusz, S.L., Liu, H., and Muatine, R.M. Composition for Increasing Bone Density. U.S. Patent 6,761,912, 2004.
58. Green, M.R., Hailes, A., Tasker, M.C., and Yates, P.R. Blends of Isoflavones and Flavones. U.S. Patent 6,617,349, 2003.
59. Gugger, E. and Grabiel, R. Production of Isoflavone Enriched Fractions from Soy Protein Extracts. U.S. Patent 6,565,912, 2003.
60. He, M.M., Liu, F.Y., Fix, J.A., Link, M., Kang, M.L., and Bombardelli, E. Tablets Incorporating Isoflavone Plant Extracts and Methods of Manufacturing Them. U.S. Patent 6,669,956, 2003.
61. Lars, H. Composition Comprising Soy Protein, Dietary Fibres and a Phytoestrogen Compound and Use Thereof in the Prevention and/or Treatment of Cardiovascular Diseases. U.S. Patent 6,630,178, 2003.
62. Kelly, G.E. Methods for Treating or Reducing Prediposition to Breast Cancer, Pre-Menstrual Syndrome or Symptoms Associated with Menopause by Administration of Phytoestrogen. U.S. Patent 6,562,380, 2003.
63. Kelly, G.E. and Husband, A.J. Therapy of Estrogen-Associated Disorders. U.S. Patent 6,599,536, 2003.
64. Kelly, G.E. Health Supplements Containing Phytoestrogens, Analogues or Metabolites Thereof. U.S. Patent 6,642,212, 2003.
65. Khare, A.B. Soluble Isoflavone Compositions. U.S. Patent 6,855,359, 2005.
66. Lu, K.M. Methods for Inhibiting Cancer Growth, Reducing Infection and Promoting General Health with a Fermented Soy Extract. U.S. Patent 6,855,350, 2005.
67. Meijer, G.W., Franke, W.C., and Reddy, P.R. Composition for Lowering Blood Cholesterol. U.S. Patent 6,787,151, 2004.
68. Monagle, C.W. Soy Protein Product and Process for Its Manufacture. U.S. Patent 6,797,309, 2004.
69. Monagle, C.W. Method for Manufacturing a Soy Protein Product. U.S. Patent 6,811,798, 2004.
70. Ono, M., Koya, K., Tatsuta, N., Yamaguchi, N., and Chen, L.B. Water-Soluble Bean-Based Extracts. U.S. Patent 6,616,959, 2003.
71. Patel, G.C., Cipollo, K.L., and Strozier, D.C. Juice and Soy Protein Beverage and Uses Thereof. U.S. Patent 6,811,804, 2004.
72. Peters, S.E. and Woods, D.H. Stable Aqueous Dispersion of Nutrients. U.S. Patent 6,617,305, 2003.
73. Singh, N. Soy Protein Concentrate Having High Isoflavone Content and Process for Its Manufacture. U.S. Patent 6,818,246, 2004.
74. Uchiyama, S., Ueno, T., Kumemura, M., Imaizumi, K., Masaki, K., and Shimizu, S. Streptococcus and Isoflavone-Containing Composition. U.S. Patent 6,716,424, 2004.
75. Uckun, F.M., Trieu, V.N., and Liu, X.P. Estrogens for Treating ALS. U.S. Patent 6,592,845, 2003.
76. Waggle, D.H., Potter, S.M., and Henley, E.C. Administering a Composition Containing Plant Sterol, Soy Protein and Isoflavone for Reducing LDL-Cholesterol. U.S. Patent 6,572,876, 2003.
77. Waggle, D.H., Potter, S.M., and Henley, E.C. Composition Containing Soy Hypocotyl Material and Plant Sterol for Reducing LDL-Cholesterol. U.S. Patent 6,579,534, 2003.
78. Waggle, D.H. and Bryan, B.A. Recovery of Isoflavones from Soy Molasses. U.S. Patent 6,664,382, 2003.
79. Waggle, D.H., Potter; S.M., and Henley, E.C. Composition Containing Isoflavone Material and Plant Sterol for Reducing LDL-Cholesterol. U.S. Patent 6,669,952, 2003.
80. Waggle, D.H. and Bryan, B.A., Recovery of Isoflavones from Soy Molasses. U.S. Patent 6,680,381, 2004.
81. Waggle, D.H. and Bryan, B.A., Recovery of Isoflavones from Soy Molasses. U.S. Patent 6,706,292, 2004.
82. Hendrich, S. Bioavailability of isoflavones. J. Chromatogr. B 777: 203-210, 2002.
83. Barnes, S., D'Alessandro, T., Kirk, M.C., Patel, R.K.P., Boersma, B.J., and Darley-Usmar, V.M., The importance of in vivo metabolism of polyphenols and their biological actions. Eds., Meskin, M.S., Bidlack, W.R., Davies, A.J., Lewis, D.S., and Randolph, R.K. In Phytochemicals: Mechanisms of Action. CRC Press, Boca Raton, FL, 2004, pp. 51-60.
84. Hendrich, S., Wang, G.-J., Lin, H.-K., Xu, X., Tew, B.-Y., Wang, H.-J., and Murphy, P.A. Isoflavone metabolism and bioavailability. In Antioxidant Status, Diet, Nutrition and Health, Ed., Papas, A.M. CRC Press, Boca Raton, FL, 1998, pp. 211-230.
85. Birt, D.F., Hendrich, S., and Wang, W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90: 157-177, 2001.
86. Fitzpatrick, L.A. Soy isoflavones: hope or hype? Maturitas 44: S21-S29, 2003.
87. Hendrich, S. Dietary estrogens. In Pesticides, Veterinary and Other Chemical Residues in Foods. Woodhead Publ. Ltd., Cambridge, U.K., pp. 436-472, 2004.
88. Birt, D.F., Hendrich, S., Anthony, M., and Alekel, D.L. Human health benefits of soybeans. Soy Monograph, Agronomy Monograph No. 16, 4th ed. American Society of Agronomy, Madison, WI. pp. 1047-1117, 2004.
89. Messina, M., Ho, S., and Alekel, D.L. Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr. Opin. Clin. Nutr. Metab. Care 7: 649-658, 2004.
90. Crouse, J.R., III, Morgan, T., Terry, J.G., Ellis, J., Vitolins, M., and Burke, G.L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159: 2070-2076, 1999.
91. Steinberg, F.M., Guthrie, N.L., Villablanca, A.C., Kumar, K., and Murray, M.J. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am. J. Clin. Nutr. 78: 123-130, 2003.
92. Yan, L. and Spitznagel, E., A meta-analysis of soyfoods and risk of breast cancer in women. Int. J. Cancer Prev. 1: 281-293, 2004.
93. Messina, M. and Hughes, C., Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J. Med. Foods 6: 1-11, 2003.
94. Strom, B.L., Schinnar, R., Ziegler, E.E., Barnhart, K.T., Sammel, M.D., Macones, G.A., Stallings, V.A., Drulis, J.M., Nelson, S.E., and Hanson, S.A. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. J. Am. Med. Assoc. 286: 807-814, 2001.
95. Bloeden, L.T., Jeffcoat, A.R., Lopaczynski, W., Schell, M.J., Black, T.M., Dix, K.J., Thomas, B.F., Albright, C., Busby, M.G., Crowell, J.A., and Zeisel, S.H. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am. J. Clin. Nutr. 76:1126-1137, 2002.
96. Yellayi, S., Naaz, A., Szewczykowski, M.A., Sato, T., Woods, J.A., Chang, J., Segre, M., Allreed, C.D., Helferich, W.G., and Cooke, P.S. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc. Natl. Acad. Sci. 99: 7616-7621, 2002.
97. Lehmann, L., Esch, H.L., Wagner, J., Rohnstock, L., and Metzler, M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells. Toxicol. Lett. 158: 72-86, 2005.
98. Alekel, D.L., St. Germain, A., Peterson, C.T., Hanson, K.B., Stewart, J.W., and Toda, T. Isoflavonerich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 72: 844-852, 2000.
99. Mei, J., Yeung, S.S.C., and Kung, A.W.C. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J. Clin. Endocrin. Metab. 86: 5217-5221, 2001.
100. Dalais, F.S., Ebeling, P.R., Kotsopoulos, D., McGrath, B.P., and Teede, H.J. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin. Endocrinol. 58: 704-709, 2003.
101. Li, B. and Yu, S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol. Pharm. Bull. 26: 780-786, 2003.
102. Park, D., Huang, T., and Frishman, W.H. Phytoestrogens as cardioprotective agents. Cardiol. Rev. 13:13-17, 2005.
103. Clarkson, T. Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 132: 566S-569S, 2002.
104. van der Schouw, Y.T., de Kleijn, M.J.J., Peeters, P.H.M., and Grobbee, D.E. Phyto-estrogens and cardiovascular disease risk. Nutr. Metab. Cardiovas. Dis. 10: 154-167, 2000.
105. Lichtenstein, A.H., Soy protein, isoflavones and cardiovascular disease risk. J. Nutr. 128: 1589-1592, 1998.
106. de Kleijn, M.J.J., van der Schouw, Y.T., Wilson, P.W.F., Grobbee, D.E., and Jacques, P.F. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile on postmenopausal U.S. women: The Framingham study. J. Nutr. 132: 276-282, 2002.
107. Song, T.T., Lee, S.O., Murphy, P.A., and Hendrich, S. Soy protein with or without isoflavones, soy germ and soy germ extract, and daidzein lessen plasma cholesterol levels in golden Syrian hamsters. Exp. Biol. Med. 228: 1063-1068, 2003.
108. Yamakoshi, J., Piskula, M.K., Izumi, T., Tobe, K., Saito, M. Kataoka, S., Obata, A., and Kikuchi, M. Isoflavone aglycone-rich extract with soy protein attenuates atherosclerosis development in cholesterol- fed rabbits. J. Nutr. 130: 1887-1893, 2000.
109. Sirtori, C.R., Bosisio, R., Pazzucconi, F., Bondioli, A., Gatti, E., Lovati, M.R., and Murphy, P. Soy milk with a high glycitein content does not reduce low-density lipoprotein cholesterolemia in Type II hypercholesterolemic patients. Ann. Nutr. Metab. 46: 88-92, 2002.
110. Greaves, K.A., Wilson, M.D., Rudel, L.L., Williams, K.J., and Wagner, J.D., Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J. Nutr. 130: 820-826, 2000.
111. Teede, H., McGrath, B.P., DeSilva, L., Cehun, M., Fassoulakis, A., and Nestel, P.J. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 23: 1066-1071, 2003.
112. Peeters, P.H.M., Keinan-Boker, L., van der Schouw, Y.T., and Grobbee, D.E. Phytoestrogens and breast cancer risk. Breast Cancer Res. Treat. 77: 171-183, 2003.
113. Jin, Z. and MacDonald, R.S. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 132: 3186-3190, 2002.
114. Lamartiniere, C.A., Wang, J., Smith-Johnson, M., and Eltoum, I.-E. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci. 65: 228-238, 2002.
115. Moyad, M.A., Soy, disease prevention, and prostate cancer. Sem. Urin. Oncol. 17: 97-102, 1999.
116. Messina, M.J. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr. Rev. 61:117-131, 2003.
117. Jacobsen, B.K., Knutsen, S.F., and Fraser, G.E. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (U.S.). Cancer Causes Control 9: 553-557, 1998.
118. Hong, S.J., Kim, S.I., Kwon, S.M., Lee, J.R., and Chung, B.C. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissue of normal control and benign prostatic hyperplasia. Yonsei Med. J. 43: 236-241, 2002.
119. Urban D., Irwin, W., Kirk, M., Markiewicz, M.A., Myers, R., Smith, M., Weiss, H., Grizzle, W.E., and Barnes, S. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J. Urol. 165: 294-300, 2001.
120. Mitchell, J.H., Duthie, S.J., and Collins, A.R. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP. Nutr. Cancer 38: 223-228, 2000.
121. Fritz, W.A., Eltoum, I.-E., Cotroneo, M.S., and Lamartiniere, C.A. Genistein alters growth but is not toxic to the rat prostate. J. Nutr. 132: 3007-3011, 2002.
122. Mentor-Marcel, R., Lamartiniere, C.A., Eltoum, I.E., Greenberg, N.M., and Elgavish, A. Genistein in the diet reduces the incidence of prostate tumors in a transgenic mouse (TRAMP). Cancer Res. 61:6777-6782, 2001.
123. Omoni, A.O., and Aluko, R.E. Soybean foods and their benefits: potential mechanisms of action. Nutr. Rev. 63: 272--283, 2005.
124. Guo, T.L., McCay, J.A., Zhang, L.X., Brown, R.D., You, L., Karrow, N.A., Germolec, D.R., and White, K.L. Jr. Genistein modulates immune responses and increases host resistance to B61F10 tumor in adult female B6C3F1 mice. J. Nutr. 131: 3251-3258, 2001.
125. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
126. Markovits, J., Linassier, C., Fosse, P., Couprie, J., Pierre, J., Jacquemin-Sablon, A., Saucier, J.M., Le Pecq, J.B., and Larsen, A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49: 5111-5117, 1989.
127. Kritz-Silverstein, D., Von Mühlen, D., Barrett-Connor, E., and Bressel, M.A.B., Isoflavones and cognitive function in older women: the SOy and postmenopausal health in aging (SOPHIA) study. Menopause 10: 196-202, 2003.
128. Mendez, M.A., Anthony, M.S., and Arab, L. Soy-based formula and infant growth and development:a review. J. Nutr. 132: 2127-2130, 2002.
129. Takimoto, C.H., Glover, K., Huang, X., Hayes, S.A., Gallot, L., Quinn, M., Jovanovic, B.D., Shapiro, A., Hernandez, L., Goetz, A., Llorens, V., Lieberman, R., Crowell, J.A., Poisson, B.A., and Bergan, R.C. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol. Biomarkers Prev. 12: 1213-1221, 2003.
130. Selvaraj, V., Zakroczymski, M.A., Naaz, A., Mukai, M., Ju, Y.H., Doerge, D.R., Katzenellenbogen, J.A., Helferich, W.G., and Cooke, P.S. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol. Reprod. 71: 966-972, 2004.
131. Selvaraj, V., Bunick, D., Finnigan-Bunick, C., Johnson, R.W., Wang, H., Liu, L., and Cooke, P.S. Gene expression profiling of 17beta-estradiol and genistein effects on mouse thymus. Toxicol. Sci. 87: 97-112, 2005.
132. Doerge, D. and Sheehan, D.M. Goitrogenic and estrogenic activity of soy isoflavones. Environ. Health Perspect. 110(Suppl. 3): 349-353, 2002.
133. Huang, W., Wood, C., L'Abbé, M., Gilani, G.S., Cockell, K.A., and Xiao, C.W., Soy protein isolate increases hepatic thyroid hormone receptor content and inhibits its binding to target genes in rats. J. Nutr. 135: 1631-1635, 2005.
134. Teede, H.J., Dalais, F.S., and McGrath, B.P. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am. J. Clin. Nutr. 79: 396-401, 2004.
135. Horn-Ross, P.L., Hoggatt, K.J., and Lee, M.M. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol. Biomark. Prev. 11: 43-49, 2002.
136. Patisaul, H.B., Dindo, M., Whitten, P.L., and Young, L.J., Soy isoflavone supplements antagonize reproductive behavior and estrogen receptor α- and β-dependent gene expression in the brain. Endocrinology 142: 2946-2952, 2001.
137. Ferguson, S.A., Flynn, K.M., Delclos, K.B., Newbold, R.R., and Gough, B.J. Effects of lifelong dietary exposure to genistein or nonylphenol on amphetamine-stimulated striatal dopamine release in male and female rats. Neurotoxicol. Teratol. 24: 37-45, 2002.
138. Lephart, E.D., West, T.W, Weber, K.S., Rhees, R.W., Setchell, K.D.R., Adlercreutz, H., and Lund, T.D. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol. Teratol. 24:5-16, 2002.
139. Lephart, E.D., Rhees, R.W., Setchell, K.D.R., Bu, L.H., and Lund, T.D. Estrogens and phytoestrogens:brain plasticity of sexually dimorphic brain volumes. J. Steroid Biochem. Mol. Biol. 85: 299-309, 2003.
140. Hartley, D.E., Edwards, J.E., Spiller, C.E., Alom, N., Tucci, S., Seth, P., Forsling, M.L., and File, S.E., The soya isoflavone content of rat diet can increase anxiety and stress hormone release in male rats. Psychopharmacology 167: 46-53, 2003.
141. Kulling, S.E., Rosenberg, B., Jacobs, E., and Metzler, M. The phytoestrogens coumestrol and genistein induce structural chromosomal aberrations in cultured human peripheral blood lymphocytes. Arch. Toxicol. 73: 50-54, 1999.
142. Tsutsui, T., Tamura, Y., Yagi, E., Hori, H., Hori, I., Metzler, M., and Barrett, J.C. Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int. J. Cancer 105:312-320, 2003.
143. Lehmann, L., Esch, H.L., Wagner, J., Rohnstock, L., Metzler, M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells. Toxicol. Lett. 158: 72-86, 2005.
144. Kuiper, G.J.M., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der Burg, B., and Gustafsson, J.-Å., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139: 4252-4263, 1998.
145. Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., Masamune, Y. Interaction of phytoestrogens with estrogen receptors αand β. Biol. Pharm. Bull. 25:48-52, 2002.
146. Rickard, D.J., Monroe, D.G., Ruesink, T.J., Khosla, S., Riggs, B.L., and Spelsberg, T.C. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors αand β. J. Cell. Biochem. 89: 633-646, 2003.
147. Mueller, S.O., Kling, M., Firzani, P.A., Mecky, A., Duranti, E., Shields-Botella, J., Delansorne, R., Broschard, T., Kramer, P.-J. Activation of estrogen receptor αand ERβby 4-methylbenzylidenecamphor in human and rat cells: comparison with phyto- and xenoestrogens. Toxicol. Lett. 142: 89-101, 2003.
148. Dechaud, H., Ravard, C., Claustrat, F., Brac de la Perriere, A., and Pugeat, M. Xenoestrogen interaction with human sex hormone-binding globulin (hSHGB). Steroids 64: 328-334, 1999.
149. Kurzer, M. Hormonal effects of soy in premenopausal women and men. J. Nutr. 132: 570S-573S, 2002.
150. Zhang, Y., Song, T.T., Cunnick, J.E., Murphy, P.A., and Hendrich, S. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells in nutritionally relevant concentrations. J. Nutr. 129: 399-405, 1999.
151. Vivier, E., Nunës, J.A., and Vèly, F., Natural killer cell signaling pathways. Science 306: 1517-1519, 2004.
152. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.-Å. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930, 1996.
153. 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans. J. Nutr. Biochem. 16: 236-244, 2005.
154. Day, A.J., Cañada, F.J., Díaz, J.C., Kroon, P.A., Mclauchlan, R., Faulds, C.B., Plumb, G.W., Morgan, M.R.A., and Williamson, G. Dietary flavonoid and isoflavone glycosides are hydrolyzed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 468: 166-170, 2000.
155. Setchell, K.D., Brown, N.M., Zimmer-Nechemias, L., Brashear, W.T., Wolfe, B.E., Kirschner, A.S., and Heubi, J.E. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 76: 447-453, 2002.
156. Williamson G. Common features in the pathways of absorption and metabolism of flavonoids. Eds., Meskin, M.S., Bidlack, W.R., Davies, A.J., Lewis, D.S., and Randolph, R.K. In Phytochemicals:Mechanisms of Action, CRC Press, Boca Raton, FL, 2004, pp. 21-33.
157. Zheng, Y., Lee, S.-O., Verbruggen, M.A., Murphy, P.A., and Hendrich, S. Apparent absorption of isoflavone glucosides and aglucons is similar in women and increased with rapid gut transit time and low fecal isoflavone degradation. J. Nutr. 134: 2534-2539, 2004.
158. Izumi, T., Piskula, M., Osawa, S., Obata, A., Tobe, K., Saito, M., Kataoka, S., Kubota, Y., and Kikuchi, M., Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 130: 1695-1699, 2000.
159. Zubik, L. and Meydani, M., Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 77: 1459-1465, 2003.
160. Setchell, K.D.R., Brown, N.M., Desai, P., Zimmer-Nechemias, L., Wolfe, B.E., Brashear, W.T., Kirschner, A.S., Cassidy, A., and Heubi, J.E., Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr., 131: 1362S-1375S, 2001.
161. Busby, M., Jeffcoat, A.R., Bloedon, L.T., Koch, M.A., Black, T., Dix, K.J., Heizer, W.D., Thomas, B.F., Hill, J.M., Crowell, J.A, and Zeisel, S.H. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am. J. Clin. Nutr. 75: 126-136, 2002.
162. King, R.A. and Bursill, D.B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 67, 867-872, 1998.
163. 13C-labeled tracers in premenopausal women. Am. J. Clin. Nutr. 77: 411-419, 2003.
164. Xu, X., Wang, H.-J., Cook, L.R., Murphy, P.A., and Hendrich, S. Daidzein is a more bioavailable soymilk isoflavone to young adult women than is genistein. J. Nutr. 124, 825-832, 1994.
165. Zhang, Y., Wang, G.-J., Song, T.T., Murphy, P.A., and Hendrich, S. Differences in disposition of the soybean isoflavones, glycitein, daidzein and genistein in humans with moderate fecal isoflavone degradation activity. J. Nutr. 129: 957-962, 1999. Erratum J. Nutr. 131: 147-148, 2001.
166. Xu, X., Harris, K., Wang, H.-J., Murphy, P., and Hendrich, S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125: 2307-2315, 1995.
167. Sfakianos, J., Coward, L., Kirk, M., and Barnes, S., Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 127: 1260-1268, 1997.
168. Chen, J., Lin, H., and Hu, M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother. Pharmacol. 55: 159-169, 2005.
169. Zhang, Y., Murphy, P.A., and Hendrich, S. Glucuronides are the main isoflavone metabolites in women. J. Nutr. 133: 399-4004, 2003.
170. Holder, C.L., Churchwell, M.I., and Doerge, D.R. Quantification of soy isoflavones, genistein and daidzein, and conjugates in rat blood using LC/ES-MS. J. Agric. Food Chem. 47: 3764-3770, 1999.
171. Cimino, C., Shelnutt, S.R., Ronis, M.J.J., and Badger, T.M. An LC-MS method to determine concentrations of isoflavones and sulfate and glucuronide conjugates in urine. Clin. Chim. Acta 287: 69-82, 1999.
172. Yasuda, T., Mizunuma, S., Kano, Y., Saito, K., and Ohsawa, K. Urinary and biliary metabolites of genistein in rats. Biol. Pharm. Bull. 19: 413-417, 1996.
173. Piskula, M. Soy isoflavone conjugation differs in fed and food-deprived rats. J. Nutr. 130: 1766-1771, 2000.
174. Peterson, T.G., Ji, G.P., Kirk, M., Coward, L., Falany, C.N., and Barnes, S. Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. Am. J. Clin. Nutr. 68(6 Suppl.), 1505S-1511S, 1998.
175. Rimbach, G., Weinberg, P.D., de Pascual-Teresa, S., Alonso, M.G., Ewins, B.A., Turner, R., Minihane, A.M., Botting, N., Fairley, B., Matsugo, S., Uchida, Y., and Cassidy, A., Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochim. Biophys. Acta 1670: 229-237, 2004.
176. Turner, R., Baron, T., Wolffram, S., Minihane, A.M., Cassidy, A., Rimbach, G., and Weinberg, P.D. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic. Res. 38: 209-216, 2004.
177. Totta, P., Acconcia, F., Virgili, F., Cassidy, A., Weinberg, P.D., Rimbach, G., and Marino, M. Daidzeinsulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-β in cultured human cancer cells. J. Nutr. 135: 2687-2693, 2005.
178. Atkinson, C., Frankenfeld, C.L., and Lampe, J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. 230: 155-170, 2005.
179. Hwang, J., Wang, J., Morazzoni, P., Hodis, H.N., and Sevanian, A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cellmediated LDL modification. Free Radic. Biol. Med. 34: 1271-1282, 2003.
180. Nettleton, J.A., Greany, K.A., Thomas, W., Wangen, K.E., Adlercreutz, H., and Kurzer, M.S. The effect of soy consumption of the urinary 2:16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption. J. Nutr. 135: 603-608, 2005.
181. Allred, C.D., Twaddle, N.C., Allred, K.F., Goeppinger, T.S., Churchwell, M.I., Ju, Y.H., Helferich, W.G., and Doerge, D.R. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice. J. Agric. Food Chem. 53: 8542-8550, 2005.
182. Lampe, J.W., Karr, S.C., Hutchins, A.M., and Slavin, J.L. Urinary equol excretion with a soy challenge:influence of habitual diet. Proc. Soc. Exp. Biol. Med. 217: 335-339, 1998.
183. Rowland, I.R., Wiseman, H., Sanders, T.A.B., Adlercreutz, H., and Bowey, E.A. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer 36: 27-32, 2000.
184. Hedlund, T.E., Maroni, P.D., Ferucci, P.G., Dayton, R., Barnes, S., Jones, K., Moore, R., Ogden, L.G., Wähälä, K., Sackett, H.M., and Gray, K.J. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J. Nutr. 135: 1400-1406, 2005.
185. Kelly, G.E., Nelson, C., Waring, M.A., Joannou, G.E., and Reeder, A.Y. Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta, 223: 9-22, 1993.
186. Heinonen, S., Wähälä, K., and Adlercreutz, H. Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6-OH-ODMA, and cis-4-OH-equol in human urine by gas chromatographymass spectrometry using authentic reference compounds. Anal. Biochem. 274: 211-219, 1999.
187. Heinonen, S., Wähälä, K., Liukkonen, K., Aura, A., Poutanen, K., and Adlercreutz, H. Studies of the in vitro intestinal metabolism of isoflavones in the identification of their urinary metabolites. J. Agric. Food Chem. 52: 2640-2646, 2004.
188. Simons, A.L., Renouf, M., Hendrich, S., and Murphy, P.A. Metabolism of glycitein (7,4-dihydroxy-6-methoxy-isoflavone) by human gut microflora. J. Agric. Food Chem. 53: 8519-8525, 2005.
189. Hendrich, S., Wang, G.-J., Xu, X., Tew, B.-Y., Wang, H.-J., and Murphy, P.A. Human Bioavailability of Soy Bean Isoflavones: Influences of Diet, Dose, Time and Gut Microflora. In Functional Foods, ACS Monograph, Ed., Shibamoto, T. ACS Books, Washington, D.C., 1998, pp. 150-156.
190. Wang, G.-J., Human Gut Microfloral Metabolism of Soybean Isoflavones. Iowa State University Master's Thesis, Ames. IA, 1997.
191. Zheng, Y., Hu, J., Murphy, P.A., Alekel, D.L., Franke, W.D., Hendrich, S., Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women. J. Nutr. 133: 3110-3116, 2003.
192. Winter J., Moore, L.H., Dowell, V.R., Jr., and Bokkenheuser, V.D. C-ring cleavage of flavonoids by human intestinal bacteria. Appl. Environ. Microbiol. 55: 1203-1208, 1989.
193. Mitsuoka, T. Recent trends in research on intestinal flora. Bifidobacteria Microflora 3, 3-24, 1982.
194. Verdeal, K. and Ryan, D.S. Naturally-occurring estrogens in plant foodstuffs - a review. J. Food Prot. 42: 577-583, 1979.
195. Markaverich, B.M., Gregory, R.R., Alejandro, M.A., Clark, J.H., Johnson, G.A., and Middleditch, B.S. Methyl p-hydroxyphenyllactate - an inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites. J. Biol. Chem. 263: 7203-7210, 1988.
196. Muyzer, G., De Wall, E.C., and Uitterlinden, A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59: 695-700, 1993.